Medtronic Aims to Be No. 2 in Surgical Robotics as Intuitive Installs 362 da Vinci 5 Systems

Source: MedRobot; Editor: Sophia

Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.

# Medtronic

MedtronicHugo Robotic-Assisted Surgery SystemIt is a split-type surgical platform, mainly used for soft tissue surgery.Medtronic CEO Geoff Martha's introduction,The company has made significant progress in its surgical robot platform, especiallyAchieved a year-on-year doubling growth in the number of surgeries.

He said: "We are confident in our position in the surgical robotics field and expect to become a strong second-place player, just behind the industry leader."Although he did not mention Intuitive Surgical. Martha added, 'Our goal is usually to be the first in the industry, butCurrently, we are setting our goals in robotics as the second., I think this is quite good as well."Medtronic aims to gradually expand its share in the surgical robot market through continuous technological innovation and market layout.

• Research Progress
  

On May 24, 2024, Medtronic announced the launch of additional clinical studies for its Hugo robotic-assisted surgery system to expand its indications.Hernia Repair SurgeryAndGynecological Field。The study is aimed to support the submission of Hugo RAS System for FDA approval.

On November 19, 2024, Medtronic announced its plan to submit an application to the U.S. FDA for the use of its Hugo surgical robot in urological indications in early 2025.

Previously, Medtronic launched the Hugo surgical robotThe first IDE study, Expand URO Clinical Trial, is nearing completion.TheResearch focuses on urological surgeries, such as prostatectomy, radical cystectomy, and nephrectomy (partial or radical).

• Review of Medtronic Soft Tissue Robot Progress Over the Years
  

In June 2021, the Hugo RAS system completed the world's first patient surgery using this system in Chile — a robotic prostatectomy. Since then, Medtronic has collaborated with local hospitals to refine its market layout in Latin America.

In October 2021, the Medtronic Hugo RAS SystemObtained EU CE Certification，Approved for sale in Europe, used in urology and gynecology surgeries. This is an important milestone in the commercialization of the Hugo RAS system.

In the fourth quarter of 2021, Medtronic began selling the Hugo RAS system outside the United States.Achieve Revenue. Guy's and St Thomas' Hospital in London, UK, has becomeThe First in the UKIntroduction of Medtronic Hugo Robot in Medical Institutions.

In October 2023, at the 6th China International Import Expo (CIIE), Medtronic announced that a training center for the Hugo RAS robot-assisted surgical system has been established in Taiwan, China, providing precision minimally invasive surgical training for surgeons from the Asia-Pacific region and locally.

Medtronic's Hugo Soft Tissue Surgical Robot Has Achieved Significant Commercial Progress in Europe, Latin America, and Asia, and Is Expected to Challenge the Market Position of the Da Vinci Surgical Robot Worldwide in the Future.

• AI + Surgical Robot

February 2020,MedtronicAcquisition of Digital Surgery, which owns a surgical training platform for doctors based on clinical video data analysis, utilizing technologies such as computer vision, AI algorithms, and augmented reality.

In July 2024, Medtronic announced itsTouch Surgery Digital Surgical SystemUpdatedLive streaming feature, including 14 new AI algorithms, can enhance postoperative analysis functions.Provide AI-based surgical insights for laparoscopic surgical robots and other robot-assisted surgeries.

Related Reading:AI Empowers Surgical Robots! Medtronic Makes Another Big Move

In addition, Medtronic also plans to launch in 2025ICG (Indocyanine Green) Visualization Technology`, and the market-leading`Vascular Ligation TechniqueIntegrated into the Hugo system, these new technologies are expected to further enhance the competitiveness of the Hugo system in clinical applications.

News on November 21, 2024: Medtronic AcquisitionJoint Manufacturer Fortimedix Surgical。The latter uses a technology that involves multi-layer laser-cut tubes nested and welded together, transforming metal tubes into flexible articulated shafts. These shafts, when assembled, contain hundreds of moving parts.Used forHandheld (Non-Robotic)AndRobotics applications, including multi-port and single-port soft tissue robots, flexible robots, and robotic endoscopic surgery。

# Intuitive Medical

Unlike Medtronic, Intuitive Surgical has been leading the surgical robotics industry for many years.On March 14, 2024, Intuitive Medical announced that its next-generation multi-port surgical robotic system, da Vinci 5, received U.S. FDA 510(k) clearance.

Although this system is still in the limited installation phase, its launch has undoubtedly driven a new wave of equipment installation enthusiasm in the U.S. market.

Related Reading:The 5th Generation is Here! Enhanced Da Vinci Launches with a Bang!

• Latest Financial Report

On January 15, 2025, Intuitive Medical announced the preliminary unaudited financial results for the fourth quarter and full year of 2024.2024A total of installations in the fourth quarter493 unitsDa Vinci Surgical System,A total of1526 units, among which362 UnitsFor the Da Vinci 5 system.

As of September 30, 2024, the global installed base of da Vinci surgical robots is9,539 units, and added 415 units in the fourth quarter,As of now, the global total installed capacity has reached10,032 units, breaking ten thousand for the first time.

Preliminary 2024 full-year revenue is approximately8.35 billion USDYuan(approximately RMB 61.2 billion),Compared with US$7.12 billion in 2023Growth17%。

The launch of the Da Vinci 5 system marks Intuitive Medical's technological advancement and market expansion in the field of surgical robotics. Although the promotion of this system is still in its early stages.stage, but the number of installations and completed surgeries demonstrates strong market demand. Intuitive Medical, relying on its years of market accumulation and technical advantages, continues to consolidate its dominant position in the global medical robotics market.

After the latest financial report was released,MarketMaintained the "Buy" rating for Intuitive MedicalThey pointed out that the surgical volume of the da Vinci 5 system exceeded expectations, and Intuitive is expected to continue its growth expansion by 2025.

# Market Competition Landscape

Medtronic and Intuitive Surgical Compete in the Surgical Robotics Space, Showcasing the Increasingly Fierce Market Battle in This Industry.

Medtronic, with its continuous innovation in the Hugo system and related technologies, is gradually expanding from traditional areas of strength such as cardiac rhythm management to a broader range of surgical applications. It aims to secure the second position in the robotic surgery market within the next few years. Meanwhile, Intuitive Surgical continues to solidify its position as an industry leader with its well-established da Vinci system and the newly launched da Vinci 5.

Whether it is the progress of Medtronic or the market performance of Intuitive Medical, it shows that the category of surgical robots is gradually moving towards maturity and becoming an important part of the global medical industry.With the continuous development of technology and the expansion of clinical indications, medical robots will play an increasingly important role in improving surgical accuracy, reducing patient suffering, and shortening recovery time.

MedRobot believesNotThe upcoming market competition will be more intense, but it will indeed push this category into the mainstream.